These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19016331)

  • 41. An Alternative to Topical Dosing to Deliver Drugs to Target Tissues.
    Waterbury LD
    J Ocul Pharmacol Ther; 2017; 33(1):3-4. PubMed ID: 27923107
    [No Abstract]   [Full Text] [Related]  

  • 42. Preparation, characterization, and pharmacokinetics of the inclusion complex of genipin-beta-cyclodextrin.
    Lu Y; Zhang T; Tao J; Ji G; Wang S
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1452-9. PubMed ID: 19929204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymeric surfactant based etodolac chewable tablets: formulation and in vivo evaluation.
    Ibrahim MM; El-Nabarawi M; El-Setouhy DA; Fadlalla MA
    AAPS PharmSciTech; 2010 Dec; 11(4):1730-7. PubMed ID: 21136309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.
    Joguparthi V; Anderson BD
    Pharm Res; 2008 Nov; 25(11):2505-15. PubMed ID: 18642063
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposomal formulations of prilocaine: effect of complexation with hydroxypropyl-ß-cyclodextrin on drug anesthetic efficacy.
    Bragagni M; Maestrelli F; Mennini N; Ghelardini C; Mura P
    J Liposome Res; 2010 Dec; 20(4):315-22. PubMed ID: 20109055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Itraconazole-hydroxypropyl-β-cyclodextrin loaded deformable liposomes: in vitro skin penetration studies and antifungal efficacy using Candida albicans as model.
    Alomrani AH; Shazly GA; Amara AA; Badran MM
    Colloids Surf B Biointerfaces; 2014 Sep; 121():74-81. PubMed ID: 24937135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation, characterization and pharmacokinetics of liposomes-encapsulated cyclodextrins inclusion complexes for hydrophobic drugs.
    Chen H; Gao J; Wang F; Liang W
    Drug Deliv; 2007 Apr; 14(4):201-8. PubMed ID: 17497352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ketorolac trometamol topical formulations: release behaviour, physical characterization, skin permeation, efficacy and gastric safety.
    El-Setouhy DA; El-Ashmony SM
    J Pharm Pharmacol; 2010 Jan; 62(1):25-34. PubMed ID: 20722996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of physicochemical properties, skin permeation and accumulation profiles of ketorolac fatty ester prodrugs.
    Bhandari KH; Newa M; Yoon SI; Kim JS; Jang KY; Kim JA; Yoo BK; Woo JS; Lee JH; Kim DD; Choi HG; Yong CS
    Biol Pharm Bull; 2007 Nov; 30(11):2211-6. PubMed ID: 17978504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chiral pharmacokinetics of ketorolac in sheep after intravenous and intramuscular administration of the racemate.
    Santos Y; Ballesteros C; Ros JM; Lázaro R; Rodríguez C; Encinas T
    J Vet Pharmacol Ther; 2001 Dec; 24(6):443-6. PubMed ID: 11903876
    [No Abstract]   [Full Text] [Related]  

  • 51. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meloxicam β-cyclodextrin transdermal gel: physicochemical characterization and in vitro dissolution and diffusion studies.
    Rasool BK; Gareeb RH; Fahmy SA; Rasool AA
    Curr Drug Deliv; 2011 Jul; 8(4):381-91. PubMed ID: 21453259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the complexation of diflunisal with hydroxypropyl-beta-cyclodextrin.
    Ugwu SO; Alcala MJ; Bhardwaj R; Blanchard J
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):391-7. PubMed ID: 10704104
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin.
    Shaker DS; Ghanem AH; Li SK; Warner KS; Hashem FM; Higuchi WI
    Int J Pharm; 2003 Mar; 253(1-2):1-11. PubMed ID: 12593932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclodextrin/Adamantane-Grafted Polyethylene Glycol-Based Self-assembling Constructs for Topical Delivery of Ketorolac Tromethamine: Formulation, Characterization, and In Vivo Studies.
    Abdellatif AAH; Mohammed AM; Zayed G; El-Rasoul SA; Almawash S; Safwat MA; Osman SK
    AAPS PharmSciTech; 2022 Jan; 23(1):45. PubMed ID: 34981280
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD.
    Zia V; Rajewski RA; Stella VJ
    Pharm Res; 2001 May; 18(5):667-73. PubMed ID: 11465424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amisulpride-CD-Loaded Liposomes: Optimization and In Vivo Evaluation.
    Shukr MH; Ahmed Farid OA
    AAPS PharmSciTech; 2018 Aug; 19(6):2658-2671. PubMed ID: 29943282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
    Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketorolac tromethamine liposomes: encapsulation and release studies.
    Ruozi B; Tosi G; Forni F; Angela Vandelli M
    J Liposome Res; 2005; 15(3-4):175-85. PubMed ID: 16393909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.